Literature DB >> 22971419

Recurrent unexplained hyperammonemia in an adolescent with arginase deficiency.

Yan Zhang1, Yuval E Landau, David T Miller, Deborah Marsden, Gerard T Berry, Mark D Kellogg.   

Abstract

OBJECTIVES: This report investigates the etiology of recurrent episodic elevations in plasma ammonia in an adolescent male with arginase deficiency as there were concerns regarding pre-analytical and analytical perturbations of ammonia measurements. There were repeated discrepancies between the magnitude of his ammonia levels and the severity of his clinical signs of hyperammonemia. PATIENT AND METHODS: The patient is a fourteen-year-old arginase-deficient male diagnosed at three years of age. Since 2008 (when he reached 10 years of age), there appeared to be an increase in the frequency of hospitalizations with elevated ammonia. A typical emergency visit with initial ammonia of 105 μmol/L (reference interval: 16-47 μmol/L) is illustrated. Pre-analytical and analytical procedures for the patient's sample handling were retrospectively examined. His ammonia levels were compiled since diagnosis. The frequency of his initial or peak ammonia levels greater than two times (94 μmol/L) or four times (188 μmol/L) the upper limit of normal was computed. Student t-test was used to calculate the significance of the differences before 2008 and since 2008.
RESULTS: One out of eleven and ten out of 19 hospitalizations had initial ammonia greater than two times normal before and after 2008, respectively. Both the patient's overall ammonia and peak ammonia levels are significantly higher since 2008 (p value <0.001 for both) than those before 2008.
CONCLUSIONS: To our knowledge, few adolescent males with arginase deficiency experience recurrent episodes of hyperammonemia requiring intravenous nitrogen scavenging agents. We hope that this study provides new insights into the natural history of arginase deficiency and the management of such patients.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22971419     DOI: 10.1016/j.clinbiochem.2012.08.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia.

Authors:  Husniye Yucel; Çiğdem Seher Kasapkara; Meltem Akcaboy; Erhan Aksoy; Gülseren Evirgen Sahin; Betul Emine Derinkuyu; Saliha Senel; Serdar Ceylaner
Journal:  Metab Brain Dis       Date:  2018-06-30       Impact factor: 3.584

2.  Guidelines for acute management of hyperammonemia in the Middle East region.

Authors:  Majid Alfadhel; Fuad Al Mutairi; Nawal Makhseed; Fatma Al Jasmi; Khalid Al-Thihli; Emtithal Al-Jishi; Moeenaldeen AlSayed; Zuhair N Al-Hassnan; Fathiya Al-Murshedi; Johannes Häberle; Tawfeg Ben-Omran
Journal:  Ther Clin Risk Manag       Date:  2016-03-31       Impact factor: 2.423

3.  Encephalopathy mimicking non-convulsive status Epilepticus.

Authors:  Ramachandiran Nandhagopal; Fathiya Al-Murshedi; Mujahid Al-Busaidi; Amna Al-Busaidi
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.